Concepedia

Fumihito Ushiyama

FU

Statistics

Publications

4

Citations

133

H-Index

4

Active since

2020

Affiliations

Taisho Pharmaceutical (Japan)(Current)

Fumihito Ushiyama is an author at Taisho Pharmaceutical (Japan) specializing in pharmacy, medicinal chemistry, and drug discovery.

ORCID

Publications per year

2020–2020

4

Publications

4

Lead Identification of 8-(Methylamino)-2-oxo-1,2-dihydroquinoline Derivatives as DNA Gyrase Inhibitors: Hit-to-Lead Generation Involving Thermodynamic Evaluation

Fumihito Ushiyama, Hideaki Amada, Tomoki Takeuchi et al. · ACS Omega · 2020 · 61 citations · Full text

, , +17

Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity

Yousuke Yamada, Hajime Takashima, Lee Walmsley et al. · Journal of Medicinal Chemistry · 2020 · 31 citations · Full text

, , +16

Lead optimization of 2-hydroxymethyl imidazoles as non-hydroxamate LpxC inhibitors: Discovery of TP0586532

Fumihito Ushiyama, Hajime Takashima, Yohei Matsuda et al. · Bioorganic & Medicinal Chemistry · 2020 · 23 citations · Full text

, , +9

Lead optimization of 8-(methylamino)-2-oxo-1,2-dihydroquinolines as bacterial type II topoisomerase inhibitors

Fumihito Ushiyama, Hideaki Amada, Yasuhiro Mihara et al. · Bioorganic & Medicinal Chemistry · 2020 · 18 citations · Full text

, , +14

1–4 of 4